Novolog (Pharm-Up 1966) Ltd (NVLG.TA)

ILA 181.1

(0.39%)

Long Term Debt Summary of Novolog (Pharm-Up 1966) Ltd

Novolog (Pharm-Up 1966) Ltd's latest annual long term debt in 2023 was 187.66 Million ILS , down -1.0% from previous year.
Novolog (Pharm-Up 1966) Ltd's latest quarterly long term debt in 2024 Q2 was 180.34 Million ILS , down 0.0% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported annual long term debt of 189.56 Million ILS in 2022, up 29.59% from previous year.
Novolog (Pharm-Up 1966) Ltd reported annual long term debt of 146.28 Million ILS in 2021, up 6.02% from previous year.
Novolog (Pharm-Up 1966) Ltd reported quarterly long term debt of 182.59 Million ILS for 2024 Q1, down -100.0% from previous quarter.
Novolog (Pharm-Up 1966) Ltd reported quarterly long term debt of 177.38 Million ILS for 2023 Q3, down -2.41% from previous quarter.

Annual Long Term Debt Chart of Novolog (Pharm-Up 1966) Ltd (2023 - 2014)

Historical Annual Long Term Debt of Novolog (Pharm-Up 1966) Ltd (2023 - 2014)

Year	Long Term Debt	Long Term Debt Growth
2023	187.66 Million ILS	-1.0%
2022	189.56 Million ILS	29.59%
2021	146.28 Million ILS	6.02%
2020	137.97 Million ILS	-2.55%
2019	141.58 Million ILS	25228.8%
2018	559 Thousand ILS	-78.59%
2017	2.61 Million ILS	0.0%
2016	- ILS	0.0%
2015	- ILS	0.0%
2014	- ILS	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	180.34 Million ILS	0.0%
2024 Q1	182.59 Million ILS	-100.0%
2023 Q3	177.38 Million ILS	-2.41%
2023 Q2	181.76 Million ILS	-1.86%
2023 Q1	185.19 Million ILS	-2.3%
2023 FY	187.66 Million ILS	-1.0%
2023 Q4	187.66 Million ILS	5.79%
2022 Q4	189.56 Million ILS	-3.45%
2022 FY	189.56 Million ILS	29.59%
2022 Q2	188.07 Million ILS	-1.02%
2022 Q1	190.01 Million ILS	29.9%
2022 Q3	196.33 Million ILS	4.4%
2021 Q3	139.72 Million ILS	5.51%
2021 Q2	132.42 Million ILS	-1.26%
2021 FY	146.28 Million ILS	6.02%
2021 Q1	134.12 Million ILS	-2.79%
2021 Q4	146.28 Million ILS	4.69%
2020 Q1	139.51 Million ILS	-1.47%
2020 Q3	131.36 Million ILS	-2.84%
2020 Q2	135.2 Million ILS	-3.08%
2020 FY	137.97 Million ILS	-2.55%
2020 Q4	137.97 Million ILS	5.03%
2019 Q1	143.97 Million ILS	25656.53%
2019 FY	141.58 Million ILS	25228.8%
2019 Q4	141.58 Million ILS	-0.98%
2019 Q3	142.98 Million ILS	-3.95%
2019 Q2	148.87 Million ILS	3.4%
2018 Q4	559 Thousand ILS	-1.76%
2018 FY	559 Thousand ILS	-78.59%
2018 Q1	2.16 Million ILS	-17.04%
2018 Q2	826 Thousand ILS	-61.87%
2018 Q3	569 Thousand ILS	-31.11%
2017 Q2	- ILS	0.0%
2017 Q1	- ILS	0.0%
2017 Q3	- ILS	0.0%
2017 Q4	2.61 Million ILS	0.0%
2017 FY	2.61 Million ILS	0.0%
2016 Q1	- ILS	0.0%
2016 FY	- ILS	0.0%
2016 Q4	- ILS	0.0%
2016 Q3	- ILS	0.0%
2015 Q4	- ILS	0.0%
2015 FY	- ILS	0.0%
2014 FY	- ILS	0.0%

Peer Long Term Debt Comparison of Novolog (Pharm-Up 1966) Ltd

Name	Long Term Debt	Long Term Debt Difference